University of Minnesota. Driven to Discover.
(CIDRAP News) – The US government has awarded Chiron Corp. a $62.5 million contract to make a vaccine for H5N1 avian influenza as part of efforts to prepare for a possible human flu pandemic.
Also, phase 2 trials just launched for two prime-boost Ebola vaccine regimens.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyAcademic Health Center, University of Minnesota, Minneapolis, MN
© 2018 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.